Nextech Invest, Ltd. Mersana Therapeutics, Inc. Transaction History
Nextech Invest, Ltd.
- $430 Billion
- Q1 2025
A detailed history of Nextech Invest, Ltd. transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Nextech Invest, Ltd. holds 12,067,246 shares of MRSN stock, worth $3.98 Million. This represents 0.97% of its overall portfolio holdings.
Number of Shares
12,067,246Holding current value
$3.98 Million% of portfolio
0.97%Shares
1 transactions
Others Institutions Holding MRSN
# of Institutions
115Shares Held
98MCall Options Held
16.3KPut Options Held
13K-
Nextech Invest Ag12.1MShares$3.98 Million3.22% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$2.86 Million0.99% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$2.77 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.38MShares$2.76 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY7.61MShares$2.51 Million0.02% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $32.1M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...